Skip to content

BIPAP AVAPS 00 (REF 1160P)Recalls & reported problems

Respironics, Inc. · BiPAP AVAPS C-Series Domestica FGD SA · Class 2

Adverse event reports
4
Deaths reported
2
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00606959039216), received between Dec 27, 2017 and Dec 13, 2024 — classified as 2 deaths, 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Degraded” (1 report).

1 other recall cover devices cleared under the same FDA submission (K102465); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 1 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 1 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Degraded1
  • Device Displays Incorrect Message1
  • Device Inoperable1
  • Insufficient Device Problem Information1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • Hypoventilation1
  • Insufficient Information1
  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • DeathDec 13, 2024Degraded; Degraded

    THE MANUFACTURER WAS CONTACTED IN REFERENCE TO THE VOLUNTARY FIELD SAFETY NOTICE / RECALL NOTIFICATION RELATED TO THE SOUND ABATEMENT FOAM IN CERTAIN CPAP, BIPAP, AND MECHANICAL VENTILATOR DEVICES. THE MANUFACTURER RECEIVED INFORMATION ALLEGES DEATH. THERE WAS NO REPORT OF MEDICAL INTERVENTION. NO ADDITIONAL INFORMATION CAN BE REQUESTED AT THIS TIME. THE MANUFACTURER WAS MADE AWARE OF THIS COMPLAINT THROUGH A REPRESENTATIVE OF THE CUSTOMER. AT THIS TIME, NO FURTHER INVESTIGATION CAN BE PERFORMED. IF ANY ADDITIONAL INFORMATION IS RECEIVED, A FOLLOW UP REPORT WILL BE FILED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20928819 ↗
  • DeathJul 22, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE MANUFACTURER RECEIVED INFORMATION ALLEGING THE PATIENT PASSED AWAY. THERE WAS NO ALLEGATION OF DEVICE MALFUNCTION. THE DEVICE HAS NOT BEEN RETURNED TO THE MANUFACTURER. AT THIS TIME, WE ARE UNABLE TO CONFIRM THE ALLEGED MALFUNCTION. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE MANUFACTURER'S INVESTIGATION IS COMPLETE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19794644 ↗
  • InjuryFeb 3, 2021Insufficient Device Problem Information; Insufficient Device Problem Information

    THE MANUFACTURER RECEIVED INFORMATION ALLEGING A BIPAP C-SERIES DEVICE SHUT DOWN WHILE IN PATIENT USE. THE PATIENT WAS ADMITTED TO THE HOSPITAL. THE DEVICE HAS YET TO BE RETURNED TO THE MANUFACTURER FOR EVALUATION. A FOLLOW UP REPORT WILL BE SUBMITTED WHEN THE MANUFACTURER HAS COMPLETED THE INVESTIGATION.

    Patient problems: Insufficient Information

    MAUDE report 11273626 ↗
  • MalfunctionDec 27, 2017Device Inoperable; Device Displays Incorrect Message; Device Displays Incorrect Message

    THE MANUFACTURER RECEIVED INFORMATION ALLEGING A BIPAP AVAPS C SERIES ALARMED AND HAD A VENTILATOR INOPERATIVE CONDITION. THE PATIENT WAS ADMITTED TO THE HOSPITAL. THE DEVICE HAS YET TO BE RETURNED TO THE MANUFACTURER FOR EVALUATION. A FOLLOW UP REPORT WILL BE SUBMITTED WHEN THE MANUFACTURER HAS COMPLETED THE INVESTIGATION.

    Patient problems: Hypoventilation; No Known Impact Or Consequence To Patient

    MAUDE report 7148632 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K102465. One submission often covers many models, so check the product and lot details in each record.

  • Z-1973-2021 · Jun 14, 2021 · Open, Classified
    DreamStation ASV, DreamStation ST, AVAPS, SystemOne ASV4, C-Series ASV, C-Series S/T and AVAPS, OmniLab Advanced+ Continuous Ventilator, Non-life Supporting The Philips Respiron

Other VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING devices

All VENTILATOR, CONTINUOUS, NON-LIFE-SUPPORTING devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.